Go to main content.

Media Release

Alcon highlights surgical innovations at 2016 EURETINA / European Society of Cataract and Refractive Surgeons (ESCRS) congresses

  • NGENUITY® 3D Visualization System designed to deliver enhanced visualization of the back of the eye for improved surgeon experience
  • Alcon’s new online Toric IOL Calculator offers best-in-class way to optimize outcomes for cataract/astigmatism patients
  • The Alcon Foundation collaborates with ESCRS to support a charitable program in Cameroon, Africa  


Fort Worth, September 07, 2016 – Alcon, the global leader in eye care and a division of Novartis, unveils an extensive program at the 16th EURETINA congress and XXXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place in Copenhagen, Denmark, September 8-14. This year’s plan showcases Alcon’s latest technological innovations in cataract, refractive and retinal surgeries.

“Alcon is proud to showcase our latest advances designed to enhance surgeon performance during cataract, refractive and retinal procedures,” said Franck Leveiller, Global Head of Research & Development at Alcon.

At the Alcon booth (C307) and during the Alcon education sessions, delegates will be able to discover our intraocular lenses (IOL) and experience the company latest technologies:

  • NGENUITY 3D Visualization System: a technological platform for Digitally-Assisted Vitreoretinal Surgery to guide surgeon decision-making during retinal surgeries. The NGENUITY 3D Visualization System features digital filters that may enhance visualization, facilitates operating using lower light levels and its high-dynamic range OLED screen which provides increased color contrast with comparable depth of field. The design may improve surgeon posture to reduce fatigue.
  • Online Toric IOL Calculator: a tool aimed for patients with corneal astigmatism. The calculator includes an optimized user interface and integrates the Barrett Toric Algorithm which demonstrated superior preoperative refractive predictability versus other formulas and nomograms.1 This best-in-class tool theoretically accounts for posterior corneal astigmatism, calculates patient-specific effective lens position and is designed to improve preoperative refractive predictability by using a centroid value for surgically induced astigmatism.1,2,3 The new online Alcon Toric IOL Calculator is  available in more than 20 languages.
  • The Contoura™ Vision System: a Topography-Guided LASIK treatment designed to provide surgeons the ability to perform personalized laser procedures based on the unique corneal topography of each eye. In a recent US multicenter clinical trial4, Contoura™ Vision achieved better unaided visual acuity 12 months after surgery than with glasses or contact lenses prior to surgery. 92.6% of eyes that received Topography-Guided LASIK treatment achieved 20/20 vision or better: specifically, 64.8% experienced 20/16 vision or better, and 34.4% could see 20/12.5 or better, 12 months after surgery. The procedure also showed statistically significant reductions in some of the visual symptoms associated with LASIK, such as glare, light sensitivity, difficulty driving at night and difficulty while reading. Contoura™ Vision can be performed with WaveLight® EX500 Excimer Laser Systems, in conjunction with the WaveLight® Topolyzer™ Vario Diagnostic Device.

This year, the Alcon Foundation is partnering with the ESCRS to organize a digital archery activity. Open to all delegates, this activity will be held every day at the Alcon booth. At the end of the congress, the Alcon Foundation will contribute € 25,000 to support an Orbis comprehensive eye health program designed to develop and increase access to high-quality eye care services at Yaoundé Central Hospital in Cameroon, Africa.

“Alcon has been a partner of Orbis for more than 30 years and has helped equip our flying eye hospitals with state of the art eye care equipment. Today we are thrilled to collaborate, at the ESCRS congress, to increase quality, efficiency, and accessibility of eye health services in an area where access to treatment has been limited,” said Bob Ranck, President and CEO of Orbis International. “We hope many delegates will take part to this activity and help us change the lives of many people in need!”

Alcon’s educational program will focus on complex cases in cataract refractive and retinal surgeries, presented by European experts:

Vitreoretinal Surgery in 3D: Improving Visualization and more (Symposium)

Saturday, Sept 10th - Timing: 10:00 – 11:00 - Bella Center – Hall C5, Auditorium C6

Establishing a new benchmark in daily cataract surgery (Symposium)

Sunday, Sept 11th - 13:00 - 14:00 – Bella Center, Auditorium 15

Achieving excellence in cataract and vitreoretinal surgery: A 360°view on ophthalmic surgical challenges (Alcon INFOCUS event)

Sunday, Sept 11th - 18:00 - 21:00 - Tivoli Hotel & Congress Center - Congress Hall

State of the Art in Cataract and Refractive Surgery (Symposium)

Monday, Sept 12th - 13:00 – 14:00 - Bella Center, Hall C1

The Alcon booth will be located in the main exhibition hall (stand: C307) at the Bella Center in Copenhagen, Denmark.



  1. Abulafia A, Barrett GD, Kleinmann G, et al. Prediction of refractive outcome with toric intraocular lens implants. J Cataract Refract Surg. 2015;41(5):936-944.
  2. Abulafia A, Hill WE, Franchina M, Barrett GD. Comparison of methods to predict residual astigmatism after intraocular lens implantation. J Refract Surg. 2015;31(10):699-707.
  3. Barrett GD. Innovative toric IOL calculators and how to use them: Barrett Toric Calculator. Cataract & Refract Surg Today Europe. May 2015 supplement.
  4. FDA Clinical Trials. Allegretto Wave Eye-Q Addendum Procedure Manual T-CAT Topography-Guided Treatments. http://www.accessdata.fda.gov/cdrh_docs/pdf2/P020050S012d.pdf

About Alcon

Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our products touch the lives of more than 260 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care. Learn more at www.alcon.com.

Alcon is on Facebook. Like us at www.facebook.com/AlconEyeCare.


About The Alcon Foundation

For more than 50 years, Alcon has been partnering with non-profit organizations that make a difference in advancing eye health, knowledge transfer, research and education, as well as enhancing access to quality eye care around the world. The Alcon Foundation awards grants to qualified, U.S.-based tax-exempt public 501(c)(3) non-profit organizations that provide high-quality programs, trainings and community services with well-defined goals to enhance sight and enhance the lives of people who otherwise would not have access to proper eye care. For more information, visit www.alcon.com.


About Orbis

Orbis is a leading global non-governmental organization that has been a pioneer in the prevention and treatment of blindness for over 30 years. Orbis transforms lives by delivering the skills, resources and knowledge needed to deliver accessible quality eye care. Working in collaboration with local partners including hospitals, universities, government agencies and ministries of health, Orbis provides hands-on ophthalmology training, strengthens healthcare infrastructure and advocates for the prioritization of eye health on public health agendas. Orbis operates the world’s only Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. To learn more about Orbis and to get involved, please visit Orbis.org and follow the organization’s work on Twitter, Facebook and Instagram. 

Alcon Media Relations

Irina Ferluga
Mobile. + 41 79 824 1121
[email protected]

Saoyuth Nidh
Mobile: +41 79 969 7757
[email protected]